|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
680 a.a.
|
 |
|
|
|
|
|
|
|
174 a.a.
|
 |
|
|
|
|
|
|
|
65 a.a.
|
 |
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase/hydrolase inhibitor
|
 |
|
Title:
|
 |
Structure of m-calpain in complex with calpastatin
|
|
Structure:
|
 |
Calpain-2 catalytic subunit. Chain: a. Synonym: calpain-2 large subunit, calcium-activated neutral proteinase 2, canp 2, calpain m-type, m-calpain, millimolar-calpain. Engineered: yes. Mutation: yes. Calpain small subunit 1. Chain: b. Fragment: unp residues 88-270.
|
|
Source:
|
 |
Rattus norvegicus. Brown rat,rat,rats. Organism_taxid: 10116. Gene: capn2. Expressed in: escherichia coli. Expression_system_taxid: 562. Gene: capns1, capn4, css1. Gene: cast.
|
|
Resolution:
|
 |
|
2.40Å
|
R-factor:
|
0.201
|
R-free:
|
0.258
|
|
|
Authors:
|
 |
R.A.Hanna,R.L.Campbell,P.L.Davies
|
Key ref:
|
 |
R.A.Hanna
et al.
(2008).
Calcium-bound structure of calpain and its mechanism of inhibition by calpastatin.
Nature,
456,
409-412.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
17-Dec-07
|
Release date:
|
25-Nov-08
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
Q07009
(CAN2_RAT) -
Calpain-2 catalytic subunit from Rattus norvegicus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
700 a.a.
680 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
|
|
 |
 |
 |
 |
Enzyme class 2:
|
 |
Chains A, B:
E.C.3.4.22.53
- calpain-2.
|
|
 |
 |
 |
 |
 |
Cofactor:
|
 |
Ca(2+)
|
 |
 |
 |
 |
 |
Enzyme class 3:
|
 |
Chain C:
E.C.?
|
|
 |
 |
 |
 |
 |
 |
 |
|
Note, where more than one E.C. class is given (as above), each may
correspond to a different protein domain or, in the case of polyprotein
precursors, to a different mature protein.
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Nature
456:409-412
(2008)
|
|
PubMed id:
|
|
|
|
|
| |
|
Calcium-bound structure of calpain and its mechanism of inhibition by calpastatin.
|
|
R.A.Hanna,
R.L.Campbell,
P.L.Davies.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Calpains are non-lysosomal calcium-dependent cysteine proteinases that
selectively cleave proteins in response to calcium signals and thereby control
cellular functions such as cytoskeletal remodelling, cell cycle progression,
gene expression and apoptotic cell death. In mammals, the two best-characterized
members of the calpain family, calpain 1 and calpain 2 (micro-calpain and
m-calpain, respectively), are ubiquitously expressed. The activity of calpains
is tightly controlled by the endogenous inhibitor calpastatin, which is an
intrinsically unstructured protein capable of reversibly binding and inhibiting
four molecules of calpain, but only in the presence of calcium. To date, the
mechanism of inhibition by calpastatin and the basis for its absolute
specificity have remained speculative. It was not clear how this unstructured
protein inhibits calpains without being cleaved itself, nor was it known how
calcium induced changes that facilitated the binding of calpastatin to calpain.
Here we report the 2.4-A-resolution crystal structure of the calcium-bound
calpain 2 heterodimer bound by one of the four inhibitory domains of
calpastatin. Calpastatin is seen to inhibit calpain by occupying both sides of
the active site cleft. Although the inhibitor passes through the active site
cleft it escapes cleavage in a novel manner by looping out and around the active
site cysteine. The inhibitory domain of calpastatin recognizes multiple lower
affinity sites present only in the calcium-bound form of the enzyme, resulting
in an interaction that is tight, specific and calcium dependent. This crystal
structure, and that of a related complex, also reveal the conformational changes
that calpain undergoes on binding calcium, which include opening of the active
site cleft and movement of the domains relative to each other to produce a more
compact enzyme.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1: Overview of calpastatin domain 4 (CAST4) bound to
calpain 2. The overall structure of CAST4 (purple) bound to
the inactive C105S mutant of calpain 2. CAST4, which is
unstructured in the absence of calpain, forms three -helices
when in complex with the enzyme. Helices in subdomains A and C,
which are in contact with DIV (yellow) and DVI (orange), and the
helix in subdomain B, which is in contact with the protease core
DI and DII (blue and light blue, respectively) are shown in
ribbon representation. DIII is coloured green. Gaps in the
electron density of CAST4 are indicated by missing residues
between D589 and K594, and between N629 and P652.
|
 |
Figure 2.
Figure 2: Specific interactions of calpastatin with calpain
entering and leaving the active-site cleft. a–d, The
27-residue B-peptide^7 is coloured as follows: the residues that
make the loop out of the active site are coloured yellow, the
residues N-terminal to the loop are purple, and the residues
C-terminal to the loop are green. Other calpastatin residues are
coloured dark grey. Hydrogen-bond interactions of calpastatin
with calpain (coloured as in Fig. 1) are shown by black dashed
lines. O and N atoms are coloured red and blue, respectively. a,
Overview of calpain binding at the active site of calpain. b,
Close-up view of the calpastatin at the unprimed side of the
active site. c, Close-up view of calpastatin looping away from
the catalytic residue. d, Close-up view of calpastatin at the
primed side of the active site.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Macmillan Publishers Ltd:
Nature
(2008,
456,
409-412)
copyright 2008.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
C.Y.Lin,
T.S.Lee,
C.C.Chen,
C.A.Chang,
Y.J.Lin,
Y.P.Hsu,
and
L.T.Ho
(2011).
Endothelin-1 exacerbates lipid accumulation by increasing the protein degradation of the ATP-binding cassette transporter G1 in macrophages.
|
| |
J Cell Physiol,
226,
2198-2205.
|
 |
|
|
|
|
 |
F.Paquet-Durand,
S.Beck,
S.Michalakis,
T.Goldmann,
G.Huber,
R.Mühlfriedel,
D.Trifunović,
M.D.Fischer,
E.Fahl,
G.Duetsch,
E.Becirovic,
U.Wolfrum,
T.van Veen,
M.Biel,
N.Tanimoto,
and
M.W.Seeliger
(2011).
A key role for cyclic nucleotide gated (CNG) channels in cGMP-related retinitis pigmentosa.
|
| |
Hum Mol Genet,
20,
941-947.
|
 |
|
|
|
|
 |
I.O.Donkor
(2011).
Calpain inhibitors: a survey of compounds reported in the patent and scientific literature.
|
| |
Expert Opin Ther Pat,
21,
601-636.
|
 |
|
|
|
|
 |
S.J.Storr,
N.O.Carragher,
M.C.Frame,
T.Parr,
and
S.G.Martin
(2011).
The calpain system and cancer.
|
| |
Nat Rev Cancer,
11,
364-374.
|
 |
|
|
|
|
 |
S.K.Tyagarajan,
H.Ghosh,
G.E.Yévenes,
I.Nikonenko,
C.Ebeling,
C.Schwerdel,
C.Sidler,
H.U.Zeilhofer,
B.Gerrits,
D.Muller,
and
J.M.Fritschy
(2011).
Regulation of GABAergic synapse formation and plasticity by GSK3beta-dependent phosphorylation of gephyrin.
|
| |
Proc Natl Acad Sci U S A,
108,
379-384.
|
 |
|
|
|
|
 |
C.J.Farady,
and
C.S.Craik
(2010).
Mechanisms of macromolecular protease inhibitors.
|
| |
Chembiochem,
11,
2341-2346.
|
 |
|
|
|
|
 |
D.J.Macqueen,
M.L.Delbridge,
S.Manthri,
and
I.A.Johnston
(2010).
A newly classified vertebrate calpain protease, directly ancestral to CAPN1 and 2, episodically evolved a restricted physiological function in placental mammals.
|
| |
Mol Biol Evol,
27,
1886-1902.
|
 |
|
|
|
|
 |
H.Sorimachi,
S.Hata,
and
Y.Ono
(2010).
Expanding members and roles of the calpain superfamily and their genetically modified animals.
|
| |
Exp Anim,
59,
549-566.
|
 |
|
|
|
|
 |
J.L.Fuentes,
M.S.Strayer,
and
A.G.Matera
(2010).
Molecular determinants of survival motor neuron (SMN) protein cleavage by the calcium-activated protease, calpain.
|
| |
PLoS One,
5,
e15769.
|
 |
|
|
|
|
 |
M.Montal
(2010).
Botulinum neurotoxin: a marvel of protein design.
|
| |
Annu Rev Biochem,
79,
591-617.
|
 |
|
|
|
|
 |
Y.Ono,
K.Ojima,
F.Torii,
E.Takaya,
N.Doi,
K.Nakagawa,
S.Hata,
K.Abe,
and
H.Sorimachi
(2010).
Skeletal muscle-specific calpain is an intracellular Na+-dependent protease.
|
| |
J Biol Chem,
285,
22986-22998.
|
 |
|
|
|
|
 |
Y.Osako,
Y.Maemoto,
R.Tanaka,
H.Suzuki,
H.Shibata,
and
M.Maki
(2010).
Autolytic activity of human calpain 7 is enhanced by ESCRT-III-related protein IST1 through MIT-MIM interaction.
|
| |
FEBS J,
277,
4412-4426.
|
 |
|
|
|
|
 |
A.Trümpler,
B.Schlott,
P.Herrlich,
P.A.Greer,
and
F.D.Böhmer
(2009).
Calpain-mediated degradation of reversibly oxidized protein-tyrosine phosphatase 1B.
|
| |
FEBS J,
276,
5622-5633.
|
 |
|
|
|
|
 |
O.Toke,
Z.Bánóczi,
G.Tárkányi,
P.Friedrich,
and
F.Hudecz
(2009).
Folding transitions in calpain activator peptides studied by solution NMR spectroscopy.
|
| |
J Pept Sci,
15,
404-410.
|
 |
|
|
|
|
 |
R.Chandramohanadas,
P.H.Davis,
D.P.Beiting,
M.B.Harbut,
C.Darling,
G.Velmourougane,
M.Y.Lee,
P.A.Greer,
D.S.Roos,
and
D.C.Greenbaum
(2009).
Apicomplexan parasites co-opt host calpains to facilitate their escape from infected cells.
|
| |
Science,
324,
794-797.
|
 |
|
|
|
|
 |
S.A.Woodcock,
C.Rooney,
M.Liontos,
Y.Connolly,
V.Zoumpourlis,
A.D.Whetton,
V.G.Gorgoulis,
and
A.Malliri
(2009).
SRC-induced disassembly of adherens junctions requires localized phosphorylation and degradation of the rac activator tiam1.
|
| |
Mol Cell,
33,
639-653.
|
 |
|
|
|
|
 |
R.L.Mellgren
(2008).
Structural biology: Enzyme knocked for a loop.
|
| |
Nature,
456,
337-338.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
');
}
}
 |
|